A qualitative study exploring older smokers' attitudes and motivation toward quitting during the COVID-19 pandemic

Marisa Cordon, Ellie Eyestone, Sarah Hutchison, Daisy Dunlap, Laney Smith, Randi M Williams, Emily Kim, Jen-Yuan Kao, Alejandra Hurtado-de-Mendoza, Cassandra Stanton, Kimberly Davis, Jennifer Frey, Brady McKee, Vicky Parikh, Kathryn L Taylor, Lung Screening, Tobacco, and Health Study, Marisa Cordon, Ellie Eyestone, Sarah Hutchison, Daisy Dunlap, Laney Smith, Randi M Williams, Emily Kim, Jen-Yuan Kao, Alejandra Hurtado-de-Mendoza, Cassandra Stanton, Kimberly Davis, Jennifer Frey, Brady McKee, Vicky Parikh, Kathryn L Taylor, Lung Screening, Tobacco, and Health Study

Abstract

Older individuals who smoke are at increased risk of having severe outcomes from COVID-19, due to their long-term smoking and underlying health conditions. In this qualitative study, we explored the impact of COVID-19 on attitudes toward smoking and motivation to quit. Participants (N = 30) were enrolled in a larger ongoing randomized controlled smoking cessation trial conducted in the lung cancer screening setting. From March to May 2020, we assessed quantitative and qualitative responses to participants' overall concern about COVID-19, changes in amount smoked, and motivation to reduce/quit smoking. Responses to the quantitative questions indicated that 64.3% of participants were extremely concerned with COVID-19, 20.7% reported reductions in amount smoked, and 37.9% reported increased motivation to quit. The qualitative responses, which were transcribed and coded using Consensual Qualitative Research guidelines, expanded upon these findings by providing the content of participants' concerns, which included perceived risk of contracting COVID-19, the added stressors caused by COVID-19, and a variable impact on the amount smoked and motivation to quit. Although half of participants expressed extreme concern regarding COVID-19, fewer indicated increased motivation or reduced smoking. Qualitative themes suggested that the initial two months of the pandemic prompted some smokers to reduce or quit, but it exacerbated smoking triggers for others. Understanding how the pandemic continues to affect this vulnerable group will aid in adapting methods to support their efforts to stop smoking and remain abstinent.

Keywords: COVID-19; Older Smokers; Perceived Risk; Qualitative Study; Smoking Cessation.

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

© 2021 The Authors.

References

    1. Berlin I., Thomas D., Le Faou A.-L., Cornuz J. COVID-19 and smoking. Nicotine Tob Res. 2020;22(9):1650–1652. doi: 10.1093/ntr/ntaa059.
    1. Bommelé J., Hopman P., Hipple Walters B., Geboers C., Croes E., Fong G., Quah A., Willemsen M. The double-edged relationship between COVID-19 stress and smoking: implications for smoking cessation. Tob Induc. Dis. 2020;18(July) doi: 10.18332/tid/125580.
    1. Braun V., Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi: 10.1191/1478088706qp063oa.
    1. CDC. COVID-19 and Your Health. Centers for Disease Control and Prevention. Published December 29, 2020. Accessed January 28, 2021. .
    1. DeCuir-Gunby J.T., Marshall P.L., McCulloch A.W. Developing and using a codebook for the analysis of interview data: an example from a professional development research project. Field Methods. 2011;23(2):136–155. doi: 10.1177/1525822X10388468.
    1. Eisenberg S.-L., Eisenberg M.J. Smoking cessation during the COVID-19 epidemic. Nicotine Tob Res. 2020;22(9):1664–1665. doi: 10.1093/ntr/ntaa075.
    1. Engin A.B., Engin E.D., Engin A. Two important controversial risk factors in SARS-CoV-2 infection: obesity and smoking. Environ Toxicol Pharmacol. 2020;78:103411. doi: 10.1016/j.etap.2020.103411.
    1. Joseph A.M., Rothman A.J., Almirall D., Begnaud A., Chiles C., Cinciripini P.M., Fu S.S., Graham A.L., Lindgren B.R., Melzer A.C., Ostroff J.S., Seaman E.L., Taylor K.L., Toll B.A., Zeliadt S.B., Vock D.M. Lung cancer screening and smoking cessation clinical trials. SCALE (smoking cessation within the context of lung cancer screening) collaboration. Am J Respir Crit Care Med. 2018;197(2):172–182. doi: 10.1164/rccm.201705-0909CI.
    1. Joyce A.A., Styklunas G.M., Rigotti N.A., Neil J.M., Park E.R., Kruse G.R. Quit Experiences among Primary Care Patients Enrolled in a Smoking Cessation Pilot RCT Early in the COVID-19 Pandemic. Int. J. Environ. Res. Public Health. 2021;18(3):1011. doi: 10.3390/ijerph18031011.
    1. Kashyap V.K., Dhasmana A., Massey A., Kotnala S., Zafar N., Jaggi M., Yallapu M.M., Chauhan S.C. Smoking and COVID-19: Adding Fuel to the Flame. Int J Mol Sci. 2020;21(18):6581. doi: 10.3390/ijms21186581.
    1. Klemperer, E.M., West, J.C., Peasley-Miklus, C., Villanti, A.C., 2020. Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19. Nicotine Tob Res. Published online April 28, 2020. doi:10.1093/ntr/ntaa072.
    1. Liu, W., Tao, Z.-W., Wang, L., et al. 2020. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin. Med. J. (Engl). 2020;133(9):1032-1038. doi:10.1097/CM9.0000000000000775.
    1. Lowe, K.E., Zein, J., Hatipoglu, U., Attaway, A., 2021. Association of Smoking and Cumulative Pack-Year Exposure With COVID-19 Outcomes in the Cleveland Clinic COVID-19 Registry. JAMA Intern Med. Published online January 25, 2021. doi:10.1001/jamainternmed.2020.8360.
    1. O’Reilly M., Parker N. ‘Unsatisfactory Saturation’: a critical exploration of the notion of saturated sample sizes in qualitative research. Qual. Res. 2013;13(2):190–197. doi: 10.1177/1468794112446106.
    1. Paleiron, N., Mayet, A., Marbac, V., et al. 2021. Impact of Tobacco Smoking on the risk of COVID-19. A large scale retrospective cohort study. Nicotine Tob Res. 2021;(ntab004). doi:10.1093/ntr/ntab004.
    1. Patanavanich R., Glantz S.A. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob. Res. 2020;22(9):1653–1656. doi: 10.1093/ntr/ntaa082.
    1. Rosoff-Verbit Z., Logue-Chamberlain E., Fishman J., Audrain-McGovern J., Hawk L., Mahoney M., Mazur A., Ashare R. The Perceived Impact of COVID-19 among Treatment-Seeking Smokers: A Mixed Methods Approach. Int. J. Environ. Res. Public Health. 2021;18(2):505. doi: 10.3390/ijerph18020505.
    1. Saldaña J. The Coding Manual for Qualitative Researchers. Sage. 2009
    1. Taylor K.L., Deros D.E., Fallon S., Stephens J., Kim E., Lobo T., Davis K.M., Luta G., Jayasekera J., Meza R., Stanton C.A., Niaura R.S., Abrams D.B., McKee B., Howell J., Ramsaier M., Batlle J., Dornelas E., Parikh V., Anderson E. Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: the lung screening, tobacco, and health trial. Contemp Clin Trials. 2019;82:25–35. doi: 10.1016/j.cct.2019.05.006.
    1. WHO director-general’s opening remarks at the media briefing on COVID-19. Published March 11, 2020. Accessed October 22, 2020. .

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir